Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | ACHE | P22303 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.54 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.54 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.54 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.54 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.54 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.54 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.54 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10932459 | 0.95 | HDAC8 (0.60) | ALDH1A1KMT2AHDAC8HDAC3HDAC4 | |
| SCHEMBL2395293 | 0.90 | POLB (0.55) | ALDH1A1KMT2AHDAC8HDAC3HDAC4 | |
| SCHEMBL13747673 | 0.85 | SMN1; SMN2 (0.56) | ALDH1A1ACHEKMT2AHDAC8HDAC3 | |
| SCHEMBL27731394 | 0.83 | ALDH1A1 (0.57) | ALDH1A1ACHEKMT2AHDAC8HDAC3 | |
| SCHEMBL877279 | 0.83 | KMT2A (0.73) | ALDH1A1ACHEKMT2AHDAC8HDAC3 | |
| SCHEMBL29459522 | 0.83 | KMT2A (0.73) | ALDH1A1ACHEKMT2AHDAC8HDAC3 | |
| Hydrochloric Acid SCHEMBL9878928 | 0.81 | KMT2A (0.71) | ALDH1A1ACHEKMT2AHDAC8HDAC3 | |
| SCHEMBL12134373 | 0.81 | ALDH1A1 (0.66) | ALDH1A1ACHEKMT2AHDAC8HDAC3 | |
| SCHEMBL11754615 | 0.81 | ALDH1A1 (0.62) | ALDH1A1ACHEKMT2AHDAC8HDAC3 | |
| SCHEMBL12134368 | 0.81 | SMN1; SMN2 (0.51) | ALDH1A1ACHEKMT2AHDAC8HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9242498-B2 | Printing method, printing device, printed material and molded article | SEIKO EPSON CORPORATION (JP) | 2016-01-26 | — | — | US | disclosed |
| US-20150353751-A1 | INKJET INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, AND PROCESS FOR PRODUCING MOLDED PRINTED MATERIAL | FUJIFILM CORPORATION (JP) | 2015-12-10 | — | — | US | disclosed |
| US-8927094-B2 | Printed article and method of manufacturing printed article | SEIKO EPSON CORPORATION (JP) | 2015-01-06 | — | — | US | disclosed |
| US-7713462-B2 | Ink composition, inkjet recording method, printed material, and process for producing molded printed material | FUJIFILM CORPORATION (JP) | 2010-05-11 | — | — | US | disclosed |
| US-20090244116-A1 | INKJET RECORDING METHOD AND INKJET RECORDING SYSTEM | FUJIFILM CORPORATION (JP) | 2009-10-01 | — | — | US | disclosed |
| US-20090214797-A1 | INKJET INK COMPOSITION, AND INKJET RECORDING METHOD AND PRINTED MATERIAL EMPLOYING SAME | FUJIFILM CORPORATION (JP) | 2009-08-27 | — | — | US | disclosed |
| US-20090087626-A1 | INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, AND PROCESS FOR PRODUCING MOLDED PRINTED MATERIAL | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| EP-0968182-B1 | HYDROXAMIC AND CARBOXYLIC ACID DERIVATIVES HAVING MMP AND TNF INHIBITORY ACTIVITY | DARWIN DISCOVERY LTD (GB) | 2004-05-06 | — | — | EP | disclosed |
| US-20030207889-A1 | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity | OWEN DAVID ALAN (GB) | 2003-11-06 | — | — | US | disclosed |
| US-6118001-A | ANTICANCER AGENT; ANTIARTHRITIC AGENT | DARWIN DISCOVERY, LTD. (GB) | 2000-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030207889-A1 | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity | MMP13, MMP2, MMP9 | ALDH1A1 408/4885ACHE 1513/4885KMT2A 1581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.